CROSS-DOMAIN PATTERN
Same drug, multiple disease domains
Si306 appears in hypotheses across 3 disease domains: ALS, Alzheimer, Pancreatic cancer. Shared mediators that recur across at least two of those domains: Src.
Aggregated from the catalog. Biological interpretation of any multi-indication mechanism would require independent validation — this is a structural observation only.
ALL HYPOTHESES
Repurposing candidates for Si306
ALS 1
| Mediator | Outcome | Score | Tier | Lit. status | Trial | |
|---|---|---|---|---|---|---|
| Src | amyotrophic lateral sclerosis | 0.208 | Mid | novel signal | none |
Alzheimer 1
| Mediator | Outcome | Score | Tier | Lit. status | Trial | |
|---|---|---|---|---|---|---|
| Src | Vascular dementia | 0.208 | Mid | novel signal | none |
Pancreatic cancer 2
| Mediator | Outcome | Score | Tier | Lit. status | Trial | |
|---|---|---|---|---|---|---|
| EGFR | pancreatic ductal adenocarcinoma | 0.208 | Mid | novel signal | none | |
| Src | migration | 0.208 | Mid | partial evidence | none |
No registered trials found on ClinicalTrials.gov. This could indicate either an unexplored indication or a gap in registry coverage.
Search ClinicalTrials.gov →